INCYTE CORP
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
INCY$120.30-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(unaudited, in thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net income | $169,548 | $21,703 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 21,947 | 19,211 |
| Stock-based compensation | 59,778 | 53,379 |
| Deferred income taxes | (34,251) | (22,163) |
| Other, net | 2,954 | (2,651) |
| Unrealized (gain) loss on long term investments | (99,947) | 5,318 |
| (Gain) loss on change in fair value of acquisition-related contingent consideration | (456) | 6,196 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (1,969) | 21,091 |
| Prepaid expenses and other assets | (1,698) | (24,354) |
| Inventory | (57,197) | (33,320) |
| Accounts payable | 54,637 | (221,913) |
| Accrued and other liabilities | 105,465 | 71,900 |
| Net cash provided by (used in) operating activities | 218,811 | (105,603) |
| Cash flows from investing activities: | ||
| Sale of long term investments | — | 45 |
| Capital expenditures | (9,549) | (11,906) |
| Payments for intangible assets | — | (15,000) |
| Purchases of marketable securities | (165,808) | (54,887) |
| Sale and maturities of marketable securities | 102,245 | 53,189 |
| Net cash used in investing activities | (73,112) | (28,559) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock under stock plans | 477 | 13,988 |
| Tax withholdings related to restricted and performance share vesting | (6,174) | (2,753) |
| Payment of finance lease liabilities | (871) | (802) |
| Payment of contingent consideration | (5,845) | (6,424) |
| Net cash (used in) provided by financing activities | (12,413) | 4,009 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (676) | (199) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 132,610 | (130,352) |
| Cash, cash equivalents, and restricted cash at beginning of period | 3,215,221 | 2,953,120 |
| Cash, cash equivalents, and restricted cash at end of period | $3,347,831 | $2,822,768 |
| Supplemental Schedule of Cash Flow Information | ||
| Income taxes paid | $2,691 | $7,107 |
| Unpaid purchases of property and equipment | $383 | $3,059 |
| Leased assets obtained in exchange for new operating lease liabilities | $— | $809 |
| Leased assets obtained in exchange for new finance lease liabilities | $550 | $385 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.